EORTC
Skip to content Back to Clinical Trials Database A Phase II study of Adjuvant PALbociclib as an Alternative to CHemotherapy in Elderly patientS…
Related Articles
First Site Activated In EU-Funded DE-ESCALATE Clinical Trial On Advance Metastatic Prostate Cancer
We are delighted to announce the official start of DE-ESCALATE, a pragmatic Phase III clinical trial focusing on metastatic prostate cancer.
First Site Activated In EU-Funded DE-ESCALATE Clinical Trial On Advance Metastatic Prostate Cancer
We are delighted to announce the official start of DE-ESCALATE, a pragmatic Phase III clinical trial focusing on metastatic prostate cancer.
EORTC Publishes Its 2024 Annual Report: Driving Progress In Cancer Treatment, Together – EORTC
The European Organisation for Research and Treatment of Cancer (EORTC) announces the publication of its 2024 Annual Report, available online.
EORTC In The Spotlight At ASCO 2025
8 EORTC studies were accepted at ASCO 2025 in Chicago, 3 for oral presentation and 5 as posters.
EORTC Will Participate In The ASCO 2025 Congress
EORTC will participate in the ASCO 2025 Annual Meeting with eight abstracts, including three oral presentations and five poster sessions.
EORTC Will Participate In The ASCO 2025 Congress
EORTC will participate in the ASCO 2025 Annual Meeting with eight abstracts, including three oral presentations and five poster sessions.
EORTC Will Participate In The ASCO 2025 Congress
EORTC will participate in the ASCO 2025 Annual Meeting with eight abstracts, including three oral presentations and five poster sessions.
The 500th patient was enrolled in the ReCare cohort
We are pleased to announce that the ReCare cohort of the E²-RADIatE platform successfully enrolled its 500th patient.
EORTC Will Participate In The ASCO 2025 Congress
EORTC will participate in the ASCO 2025 Annual Meeting with eight abstracts, including three oral presentations and five poster sessions.